HUP0105070A2 - Hepatitis B vírus fertőzések megelőzésére és kezelésére szolgáló készlet - Google Patents
Hepatitis B vírus fertőzések megelőzésére és kezelésére szolgáló készletInfo
- Publication number
- HUP0105070A2 HUP0105070A2 HU0105070A HUP0105070A HUP0105070A2 HU P0105070 A2 HUP0105070 A2 HU P0105070A2 HU 0105070 A HU0105070 A HU 0105070A HU P0105070 A HUP0105070 A HU P0105070A HU P0105070 A2 HUP0105070 A2 HU P0105070A2
- Authority
- HU
- Hungary
- Prior art keywords
- hepatitis
- treatment
- prevention
- antiviral agent
- novel treatment
- Prior art date
Links
- 208000002672 hepatitis B Diseases 0.000 abstract 3
- 239000003443 antiviral agent Substances 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 241000700721 Hepatitis B virus Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 abstract 1
- 229940124736 hepatitis-B vaccine Drugs 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9900630 | 1999-01-12 | ||
| PCT/EP1999/010295 WO2000041463A2 (en) | 1999-01-12 | 1999-12-21 | Combination of hepatitis b vaccine with antiviral agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0105070A2 true HUP0105070A2 (hu) | 2002-04-29 |
Family
ID=10845878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0105070A HUP0105070A2 (hu) | 1999-01-12 | 1999-12-21 | Hepatitis B vírus fertőzések megelőzésére és kezelésére szolgáló készlet |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1140163A2 (ko) |
| JP (1) | JP2002534438A (ko) |
| KR (1) | KR20010090011A (ko) |
| CN (1) | CN1391482A (ko) |
| AR (1) | AR022250A1 (ko) |
| AU (1) | AU760574B2 (ko) |
| BR (1) | BR9916893A (ko) |
| CA (1) | CA2359110A1 (ko) |
| CO (1) | CO5241355A1 (ko) |
| CZ (1) | CZ20012544A3 (ko) |
| HK (1) | HK1041434A1 (ko) |
| HU (1) | HUP0105070A2 (ko) |
| IL (1) | IL144186A0 (ko) |
| NO (1) | NO20013337L (ko) |
| NZ (1) | NZ512890A (ko) |
| PL (1) | PL349347A1 (ko) |
| TR (1) | TR200102024T2 (ko) |
| WO (1) | WO2000041463A2 (ko) |
| ZA (1) | ZA200105690B (ko) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1077722T1 (sl) | 1998-05-22 | 2007-02-28 | Ottawa Health Research Inst | Metode in produkti za induciranje sluznicne imunosti |
| AU4932199A (en) | 1998-07-31 | 2000-02-21 | Haruo Sugiyama | Cancer antigens based on tumor suppressor gene wt1 product |
| US20040097703A1 (en) | 2001-03-22 | 2004-05-20 | Haruo Sugiyama | Wt1 modified peptide |
| US20050002951A1 (en) * | 2001-09-28 | 2005-01-06 | Haruo Sugiyama | Novel method of inducing antigen-specific t cells |
| US8735357B2 (en) | 2001-09-28 | 2014-05-27 | International Institute Of Cancer Immunology, Inc. | Method of inducing antigen-specific T cells |
| TWI275392B (en) * | 2002-04-08 | 2007-03-11 | Bristol Myers Squibb Co | Low dose liquid entecavir formulations and use |
| PT2241325E (pt) | 2002-10-29 | 2012-04-12 | Coley Pharm Gmbh | Utilização de oligonucleótidos cpg no tratamento de infecção com vírus da hepatite c |
| WO2004053104A2 (en) | 2002-12-11 | 2004-06-24 | Coley Pharmaceutical Group, Inc. | 5’ cpg nucleic acids and methods of use |
| CN100443117C (zh) * | 2003-05-13 | 2008-12-17 | 深圳康泰生物制品股份有限公司 | 一种治疗性乙型肝炎的疫苗制剂、其制备方法及其用途 |
| US8541167B2 (en) | 2004-06-03 | 2013-09-24 | Saint Louis University | Methods and compositions for vaccination |
| AR065504A1 (es) * | 2007-02-28 | 2009-06-10 | Ct Ingenieria Genetica Biotech | Terapia combinada para el tratamiento de la hepatitis b cronica. uso. |
| WO2020134682A1 (zh) * | 2018-12-24 | 2020-07-02 | 南京远大赛威信生物医药有限公司 | 用于治疗乙型肝炎的药物制剂及其制备方法和用途 |
| CN117120088A (zh) * | 2021-04-07 | 2023-11-24 | 电化株式会社 | 佐剂活性增强剂和佐剂组合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE159031T1 (de) * | 1989-07-25 | 1997-10-15 | Smithkline Biolog | Antigene sowie verfahren zu deren herstellung |
| ES2273482T3 (es) * | 1998-03-09 | 2007-05-01 | Glaxosmithkline Biologicals S.A. | Composiciones de vacunas combinadas. |
-
1999
- 1999-12-21 TR TR2001/02024T patent/TR200102024T2/xx unknown
- 1999-12-21 HU HU0105070A patent/HUP0105070A2/hu unknown
- 1999-12-21 IL IL14418699A patent/IL144186A0/xx unknown
- 1999-12-21 WO PCT/EP1999/010295 patent/WO2000041463A2/en not_active Application Discontinuation
- 1999-12-21 CN CN99816471A patent/CN1391482A/zh active Pending
- 1999-12-21 AU AU21009/00A patent/AU760574B2/en not_active Ceased
- 1999-12-21 EP EP99965531A patent/EP1140163A2/en not_active Withdrawn
- 1999-12-21 BR BR9916893-6A patent/BR9916893A/pt not_active IP Right Cessation
- 1999-12-21 KR KR1020017008833A patent/KR20010090011A/ko not_active Application Discontinuation
- 1999-12-21 NZ NZ512890A patent/NZ512890A/en unknown
- 1999-12-21 CZ CZ20012544A patent/CZ20012544A3/cs unknown
- 1999-12-21 JP JP2000593088A patent/JP2002534438A/ja active Pending
- 1999-12-21 CA CA002359110A patent/CA2359110A1/en not_active Abandoned
- 1999-12-21 PL PL99349347A patent/PL349347A1/xx not_active Application Discontinuation
-
2000
- 2000-01-11 AR ARP000100107A patent/AR022250A1/es not_active Application Discontinuation
- 2000-01-12 CO CO00001261A patent/CO5241355A1/es not_active Application Discontinuation
-
2001
- 2001-07-05 NO NO20013337A patent/NO20013337L/no not_active Application Discontinuation
- 2001-07-11 ZA ZA200105690A patent/ZA200105690B/xx unknown
-
2002
- 2002-02-19 HK HK02101211.9A patent/HK1041434A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL144186A0 (en) | 2002-05-23 |
| WO2000041463A3 (en) | 2000-11-09 |
| NO20013337L (no) | 2001-08-17 |
| NZ512890A (en) | 2003-09-26 |
| CZ20012544A3 (cs) | 2002-01-16 |
| KR20010090011A (ko) | 2001-10-17 |
| TR200102024T2 (tr) | 2001-12-21 |
| PL349347A1 (en) | 2002-07-15 |
| JP2002534438A (ja) | 2002-10-15 |
| NO20013337D0 (no) | 2001-07-05 |
| WO2000041463A2 (en) | 2000-07-20 |
| CN1391482A (zh) | 2003-01-15 |
| ZA200105690B (en) | 2002-09-25 |
| AU2100900A (en) | 2000-08-01 |
| AU760574B2 (en) | 2003-05-15 |
| EP1140163A2 (en) | 2001-10-10 |
| CO5241355A1 (es) | 2003-01-31 |
| AR022250A1 (es) | 2002-09-04 |
| CA2359110A1 (en) | 2000-07-20 |
| HK1041434A1 (zh) | 2002-07-12 |
| BR9916893A (pt) | 2001-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20104960B (en) | USE OF [D-MeALa]3-[EtVal]4-CYCLOSPORIN FOR THE TREATMENT OF HEPATITIS C INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID [D-MeAla]3-[EtVal]4-CYCLOSPORIN | |
| HUP0102441A2 (hu) | Megváltozott interferon-antagonista aktivitással rendelkező, legyengített negatívszálú vírusok vakcinaként és gyógyszerként való alkalmazásra | |
| HUP0202502A2 (hu) | Virális fertőzőképességet blokkoló peptidek és eljárások ezek alkalmazására | |
| HUP0105070A2 (hu) | Hepatitis B vírus fertőzések megelőzésére és kezelésére szolgáló készlet | |
| HUP0002224A1 (hu) | Virusellenes hatású benzimidazol-származékok | |
| BR0111195A (pt) | Uso de b-l-2'-desoxi-nucleosìdeos no tratamento de infecção por vìrus de hepatite delta | |
| BR0011433B1 (pt) | Compostos de imidazoquinolinas substituídas com sulfonamida e sulfamida e composição farmaceutica cotendo os mesmos | |
| HUP0103319A2 (hu) | Készítmények HIV- és egyéb vírusfertőzések kezelésére és alkalmazásuk | |
| HUP0400719A2 (hu) | Vegyületek és eljárások Chlamydia-fertőzés diagnosztikájára és kezelésére | |
| HUP0100100A2 (hu) | Hepatitis C inhibitor peptid-analógok, ezeket hatóanyagként tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| RS20120201A3 (en) | METHODS AND MIXTURES FOR TREATMENT OF VIRAL HEPATITIS C | |
| MY141594A (en) | 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES | |
| BR0115447A (pt) | Inibidores de tripeptìdeo de hepatite c | |
| CA2253490A1 (en) | Use of il-12 and ifn-.alpha. for the treatment of infectious diseases | |
| WO2001077091A3 (en) | Ns5b hcv polymerase inhibitors | |
| HUP0202570A1 (hu) | Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk | |
| HUP0402259A2 (hu) | Vakcinák | |
| HUP0301349A2 (hu) | IL-11-tartalmú készítmények | |
| DE69518840D1 (en) | N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren | |
| ATE486634T1 (de) | Caspase 3, 8, 9 oder 10 inhibitoren in kombination mit mek inhibitoren zur behandlung von influenza | |
| DK1053012T3 (da) | Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner | |
| HUP0200162A2 (hu) | Haemophilus somnus transzferrin-kötő fehérjék klónozása és expresszálása | |
| RU2006118106A (ru) | Вектор химерного аденовируса типа 5/типа 35 | |
| WO1988007367A3 (en) | Melatonin-derivatives for psychogenic stress and acute anxiety, and immuno-stimulant drugs | |
| WO2004006848A3 (en) | Combination therapies with ftc for the treatment of hepatitis b virus infection |